Peter G. Piferi - 20 Aug 2021 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Reporting relationship: Chief Operating Officer
Issuer ticker: CLPT
Reported as of: 20 Aug 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Aug 2021, 16:08:03 UTC
Prior SEC filing: 20 Aug 2021
Source filing: View source filing
Reporting owner signature: /s/ Richard F. Mattern, by Power of Attorney for Peter G. Piferi

Key filing fact

Peter G. Piferi filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 23 Aug 2021.

Key facts

This page summarizes Peter G. Piferi's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Aug 2021, 16:08.

Change

Previous filing in this sequence was filed on 20 Aug 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLPT transaction

Common Stock

Award

Transaction value: $0
Shares: +2,203
Change %: +3.3%
Price: $0.000000
Shares after: 68,739
Date: 20 Aug 2021
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLPT transaction Derivative

Stock Options (right to buy)

Award

Transaction value: $0
Shares: +4,406
Change %
Price: $0.000000
Shares after: 4,406
Date: 20 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,406
Exercise price: $16.71
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.

Footnote F2

The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.